Table 2.
Clinical Trials Using ARTs in COVID-19
| Study Title | Interventions | Location | Status |
|---|---|---|---|
| Evaluation of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of Novel Coronavirus Infection | Ganovo/ritonavir, interferon nebulization | China | Completed |
| The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection | Lopinavir/ritonavir, arbidol | China | Recruiting |
| Efficacy and Safety of Darunavir and Cobicistat for Treatment of Pneumonia Caused by 2019-nCoV | Darunavir, cobicistat | China | Recruiting |
| Treatment and Prevention of Traditional Chinese Medicines (TCMs) on 2019-nCoV Infection | Oxygen therapy, alfa interferon via aerosol inhalation, lopinavir/ritonavir, TCM granules | China | Recruiting |
| Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment | Lopinavir/ritonavir, ribavirin, interferon beta-1B | Hong Kong | Recruiting |
| Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19) | Lopinavir/ritonavir, hydroxychloroquine sulfate | South Korea | Recruiting |
| Trial of Treatments for COVID-19 in Hospitalized Adults | Remdesivir, lopinavir/ritonavir, interferon beta-1A, hydroxychloroquine | France | Recruiting |
| COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir | Lopinavir/ritonavir | Canada | Not yet recruiting |
| Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Hydroxychloroquine for Treatment of COVID19: A Randomized Control Trial | Oseltamivir, hydroxychloroquine, lopinavir/ritonavir, darunavir, favipiravir | Thailand | Not yet recruiting |
| The Clinical Study of Carrimycin on Treatment Patients With COVID-19 | Carrimycin, lopinavir/ritonavir, arbidol, chloroquine phosphate | Not yet recruiting | |
| Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients | Lopinavir/ritonavir, hydroxychloroquine sulfate, baricitinib, sarilumab | Not yet recruiting | |
| Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection | ASC09/ritonavir, lopinavir/ritonavir | Not yet recruiting | |
| Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia | Xiyanping injection, lopinavir/ritonavir, alpha-interferon nebulization | Not yet recruiting | |
| Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe) | Lopinavir/ritonavir, xiyanping injection | Not yet recruiting |
COVID-19 = coronavirus disease-2019; TCM = traditional Chinese medicine.